TransMedics Group Inc (TMDX)

Total asset turnover

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Revenue (ttm)	US$ in thousands	401,090	358,759	296,919	241,623	191,824	151,077	119,133	93,459	71,752	51,439	39,089	30,262	28,221	29,942	25,162	25,639	24,069	24,183	26,458	23,604
Total assets	US$ in thousands	785,571	758,577	723,831	706,047	689,227	690,358	287,088	277,147	274,873	117,285	124,008	134,893	131,146	140,512	145,783	152,026	159,322	163,137	96,923	105,299
Total asset turnover		0.51	0.47	0.41	0.34	0.28	0.22	0.41	0.34	0.26	0.44	0.32	0.22	0.22	0.21	0.17	0.17	0.15	0.15	0.27	0.22

September 30, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $401,090K ÷ $785,571K
= 0.51

TransMedics Group Inc's total asset turnover has exhibited fluctuating trends over the past several quarters. The ratio has ranged from 0.15 to 0.51, indicating varying efficiency in generating sales relative to the total assets employed.

In the most recent period, as of September 30, 2024, the total asset turnover stands at 0.51, suggesting that TransMedics is generating $0.51 in sales for every dollar of assets. This represents an improvement from the previous quarter and indicates that the company has become more efficient in utilizing its assets to drive revenue.

It is noteworthy that the total asset turnover has shown periods of both increase and decrease over the analyzed timeframe. The ratio was at its lowest in the first quarter of 2021 at 0.15 and has shown a general upward trend since then, with fluctuations along the way.

Overall, the trend in TransMedics Group Inc's total asset turnover indicates the company's ability to generate sales relative to its asset base. The recent increase in the ratio suggests improved asset utilization efficiency, which can positively impact the company's overall financial performance and profitability.